NIH-funded research R01 grant

How a mother's triglyceride levels influence newborn body and liver fat in pregnancies with obesity

Official title: Triglycerides as a Predictor of Newborn Subcutaneous and Liver Fat: Contributors to Fetal Fat Accretion in Obese Pregnancies

Funded at University of Colorado Denver · NIH-11312645 · Data updated 2026-11-12

This project looks at whether higher maternal blood triglycerides during pregnancy are linked to more body and liver fat in newborns of people with overweight or obesity.

More Newborn research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startMay 7, 2021
Project endMarch 31, 2027
Funding year2026
Award (this year)$628,340
NIH project number5R01HD102726-05
Project IDNIH-11312645 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are pregnant people with overweight or obesity who can attend prenatal visits and agree to blood tests during pregnancy and newborn imaging after delivery.

Less likely to help

People who are not pregnant, who have a normal pre-pregnancy weight, or who cannot attend study visits or deliver at the study site are unlikely to participate or benefit directly.

What this research studies

If you are pregnant and have overweight or obesity, researchers will check your blood fats (fasting and after a meal) at multiple points in pregnancy and measure sugars and cord C‑peptide at delivery. After birth, your baby will have noninvasive imaging to estimate subcutaneous and liver fat. The team will compare early- and late-pregnancy triglyceride and glucose patterns to newborn fat outcomes to understand what drives fetal fat gain. Results aim to point to biological targets that could be tested later to prevent childhood obesity and fatty liver.

Why it matters

Potential benefit: If successful, this work could point to ways to reduce newborn fat and lower the child’s future risk of obesity and fatty liver disease by targeting maternal triglycerides during pregnancy.

How similar studies have gone: Prior observational studies and animal data have linked higher maternal triglycerides to greater newborn fat and later fatty liver, but randomized trials to reduce fetal overgrowth in obese pregnancies have not yet found a clearly effective treatment.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Barbour, Linda Anne — University of Colorado Denver
  • Study coordinator: Barbour, Linda Anne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.